A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

I6F-MC-JJCD -

The main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with other anticancer agents in participants with advanced or metastatic solid tumors.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Solid Tumors
What the trial is testing?
LY3039478
Could I receive a Placebo?
No
Enrollment Goal
94
Trial Dates
Nov 4, 2016 - Feb 13, 2020
How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.